What amount sold does CLINICAL OUTCOMES MANAGEMENT SYSTEMS LLC report in Form D filings?

The latest linked filings report $750K sold across 1 identified offering(s). 3 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was CLINICAL OUTCOMES MANAGEMENT SYSTEMS LLC's most recent SEC filing?

CLINICAL OUTCOMES MANAGEMENT SYSTEMS LLC's most recent Form D filing was on 2015-11-16.

How many investors does CLINICAL OUTCOMES MANAGEMENT SYSTEMS LLC have?

The most recent Form D filing lists 4 investor(s).

What type of securities does CLINICAL OUTCOMES MANAGEMENT SYSTEMS LLC offer?

CLINICAL OUTCOMES MANAGEMENT SYSTEMS LLC's SEC Form D filings indicate equity offerings.

CLINICAL OUTCOMES MANAGEMENT SYSTEMS LLC

CIK: 0001456002·Other Technology·BROADVIEW HEIGHTS, OH·Limited Liability Company·Founded 2013

Reported Sold

$750,000

Total Filings

Identified Offerings

Last Filed

Nov 16, 2015

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 3 unlinked amendments excluded.

About

Company in Other Technology industry

SEC EDGAR

Offering filing timeline

Nov 16, 2015Form D — New notice

Reported sold: $750,000 · Target: $1,469,248

Rule 506(b)·4 investors

Nov 9, 2011Form D/A — Amendment

Reported sold: $4,900,501 · Target: $4,900,501

Rule 505·32 investors·Rule 506

Changed: Reported amount sold, Offering target, Reported investors, Sales commissions

Mar 19, 2010Form D/A — Amendment

Reported sold: $1,700,500 · Target: $3,900,500

Rule 505·16 investors·Rule 506

Changed: Reported amount sold, Offering target

Jul 20, 2009Form D/A — Amendment

Reported sold: $1,200,000 · Target: $1,655,000

No verified predecessor available.

Rule 505·16 investors·Rule 506

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

75%

Latest reported sold across 1 identified offering

$750,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

3 unlinked amendments excluded.

Key People

Thomas Albert Riemenschneider

Related Person

Appears on 2 filings

Len Pagon

Related Person

Appears on 2 filings

Donna Zapis Thomas

Related Person

Appears on 2 filings

Edward J. Tromczynksi

Related Person

Appears on 2 filings

John F Zak

Related Person

Appears on 2 filings

Frederick Croft

Related Person

Appears on 1 filing

Michael Paull

Related Person

Appears on 1 filing

Paul Carleton

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 16, 2015	New	$1,469,248	$750,000	4
Nov 9, 2011	Amendment	$4,900,501	$4,900,501	32
Mar 19, 2010	Amendment	$3,900,500	$1,700,500	16
Jul 20, 2009	Amendment	$1,655,000	$1,200,000	16

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Heylo, Inc.

Other Technology

Offering target: $2,000,000

Filed Oct 2, 2026